12:00 AM
 | 
Nov 10, 2008
 |  BC Week In Review  |  Clinical News  |  Regulatory

Sanvar IR vapreotide regulatory update

Debiopharm submitted a complete response to a 2005 FDA approvable letter for Sanvar to treat acute esophageal variceal bleeding....

Read the full 74 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >